BioLife Solutions Future Growth
Future criteria checks 4/6
BioLife Solutions is forecast to grow earnings and revenue by 62.1% and 13.3% per annum respectively. EPS is expected to grow by 62.5% per annum. Return on equity is forecast to be -2.1% in 3 years.
Key information
62.1%
Earnings growth rate
62.5%
EPS growth rate
Life Sciences earnings growth | 21.6% |
Revenue growth rate | 13.3% |
Future return on equity | -2.1% |
Analyst coverage | Good |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 159 | 7 | 9 | 22 | 3 |
12/31/2025 | 119 | -22 | -15 | 9 | 6 |
12/31/2024 | 101 | -48 | -33 | 2 | 8 |
12/31/2023 | 143 | -66 | -24 | -12 | N/A |
9/30/2023 | 155 | -102 | -22 | -7 | N/A |
6/30/2023 | 162 | -83 | -17 | -1 | N/A |
3/31/2023 | 163 | -146 | -19 | -3 | N/A |
12/31/2022 | 162 | -140 | -22 | -8 | N/A |
9/30/2022 | 155 | -106 | -28 | -17 | N/A |
6/30/2022 | 148 | -96 | -27 | -17 | N/A |
3/31/2022 | 139 | -15 | -27 | -14 | N/A |
12/31/2021 | 119 | -9 | -19 | -5 | N/A |
9/30/2021 | 97 | 5 | -19 | -2 | N/A |
6/30/2021 | 74 | 4 | -19 | -4 | N/A |
3/31/2021 | 53 | -20 | -3 | 8 | N/A |
12/31/2020 | 48 | 2 | -1 | 7 | N/A |
9/30/2020 | 42 | 7 | 0 | 3 | N/A |
6/30/2020 | 37 | 16 | 1 | 5 | N/A |
3/31/2020 | 34 | 39 | -3 | 1 | N/A |
12/31/2019 | 27 | -2 | -1 | 1 | N/A |
9/30/2019 | 25 | -32 | 2 | 3 | N/A |
6/30/2019 | 23 | -39 | 2 | 2 | N/A |
3/31/2019 | 22 | -44 | 2 | 3 | N/A |
12/31/2018 | 20 | -25 | 2 | 2 | N/A |
9/30/2018 | 17 | 1 | 2 | 3 | N/A |
6/30/2018 | 15 | 0 | 2 | 2 | N/A |
3/31/2018 | 12 | -2 | 1 | 1 | N/A |
12/31/2017 | 11 | -3 | 0 | 1 | N/A |
9/30/2017 | 10 | -5 | N/A | -1 | N/A |
6/30/2017 | 9 | -6 | N/A | -2 | N/A |
3/31/2017 | 9 | -7 | N/A | -3 | N/A |
12/31/2016 | 8 | -7 | N/A | -4 | N/A |
9/30/2016 | 8 | -5 | N/A | -5 | N/A |
6/30/2016 | 7 | -5 | N/A | -5 | N/A |
3/31/2016 | 7 | -4 | N/A | -5 | N/A |
12/31/2015 | 6 | -4 | N/A | -5 | N/A |
9/30/2015 | 6 | -4 | N/A | -4 | N/A |
6/30/2015 | 6 | -4 | N/A | -4 | N/A |
3/31/2015 | 6 | -4 | N/A | -4 | N/A |
12/31/2014 | 6 | -3 | N/A | -3 | N/A |
9/30/2014 | 7 | -3 | N/A | -2 | N/A |
6/30/2014 | 8 | -2 | N/A | -2 | N/A |
3/31/2014 | 9 | -2 | N/A | -1 | N/A |
12/31/2013 | 9 | -1 | N/A | 0 | N/A |
9/30/2013 | 9 | -1 | N/A | 0 | N/A |
6/30/2013 | 8 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BJX1 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: BJX1 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BJX1 is expected to become profitable in the next 3 years.
Revenue vs Market: BJX1's revenue (13.3% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: BJX1's revenue (13.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BJX1 is forecast to be unprofitable in 3 years.